| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Partners AIDS Research Center, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129;
Antigenics, Inc., Lexington, MA 02420; and
Center for Immunotherapy of Cancer and Infectious Diseases, University of Connecticut School of Medicine, CT 06102
Strong CD4+ and CD8+ T cell responses are considered important immune components for controlling HIV infection, and their priming may be central to an effective HIV vaccine. We describe in this study an approach by which multiple CD4+ and CD8+ T cell epitopes are processed and presented from an exogenously added HIV-1 Gag-p24 peptide of 32 aa complexed to heat shock protein (HSP) gp96. CD8+ T cell recognition of the HSP/peptide complex, but not the peptide alone, was inhibited by brefeldin A, suggesting an endoplasmic reticulum-dependent pathway. This is the first report to describe efficient processing and simultaneous presentation of overlapping class I- and class II-restricted epitopes from the same extracellularly added precursor peptide complexed to HSP. Given previous reports of the strong immunogenicity of HSP/peptide complexes, the present data suggest that HSP-complexed peptides containing multiple MHC class I- and class II-restricted epitopes represent potential vaccine candidates for HIV and other viral infections suitable to induce effective CTL memory by simultaneously providing CD4 T cell help.
This article has been cited by other articles:
|
|
 |
|
  K. Babaahmady, W. Oehlmann, M. Singh, and T. Lehner Inhibition of Human Immunodeficiency Virus Type 1 Infection of Human CD4+ T Cells by Microbial HSP70 and the Peptide Epitope 407-426 J. Virol., April 1, 2007; 81(7): 3354 - 3360. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Biswas, U. Sriram, B. Ciric, O. Ostrovsky, S. Gallucci, and Y. Argon The N-terminal fragment of GRP94 is sufficient for peptide presentation via professional antigen-presenting cells Int. Immunol., July 1, 2006; 18(7): 1147 - 1157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Bettosini, M. T. Fiorillo, A. Magnacca, L. Leone, M. R. Torrisi, and R. Sorrentino The C Terminus of the Nucleoprotein of Influenza A Virus Delivers Antigens Transduced by Tat to the trans-Golgi Network and Promotes an Efficient Presentation through HLA Class I J. Virol., December 15, 2005; 79(24): 15537 - 15546. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Qian, S. Wang, J. Yang, J. Xie, P. Lin, M. E. Freeman III, and Q. Yi Targeting Heat Shock Proteins for Immunotherapy in Multiple Myeloma: Generation of Myeloma-Specific CTLs Using Dendritic Cells Pulsed with Tumor-Derived gp96 Clin. Cancer Res., December 15, 2005; 11(24): 8808 - 8815. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. J. Quintana and I. R. Cohen Heat Shock Proteins as Endogenous Adjuvants in Sterile and Septic Inflammation J. Immunol., September 1, 2005; 175(5): 2777 - 2782. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kebba, J. Stebbing, S. Rowland, R. Ingram, J. Agaba, S. Patterson, P. Kaleebu, N. Imami, and F. Gotch Expression of the common heat-shock protein receptor CD91 is increased on monocytes of exposed yet HIV-1-seronegative subjects J. Leukoc. Biol., July 1, 2005; 78(1): 37 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. R. Tobian, C. V. Harding, and D. H. Canaday Mycobacterium tuberculosis Heat Shock Fusion Protein Enhances Class I MHC Cross-Processing and -Presentation by B Lymphocytes J. Immunol., May 1, 2005; 174(9): 5209 - 5214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. K. L. Nordstrom, M. N. E. Forsell, C. Barnfield, E. Bonin, T. Hanke, M. Sundstrom, G. B. Karlsson, and P. Liljestrom Enhanced immunogenicity using an alphavirus replicon DNA vaccine against human immunodeficiency virus type 1 J. Gen. Virol., February 1, 2005; 86(2): 349 - 354. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
